Sort
50,496 grants matching “lung cancer”
Clinical trials employing cancer vaccine combination therapies
$843,113James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$843,113James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
NIH Chronic GVHD Study Group
$843,102Steven Pavletic · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Integrative Omics as a Discovery Tool for Pulmonary Hypertension
$843,057Marlene Rabinovitch · Stanford University · R01 · FY2015 · HL
Community Engagement and Outreach Core
$842,661Paul G Spicer · University Of Oklahoma Hlth Sciences Ctr · U54 · FY2023 · GM
Center for Applied Preclinical Research (CAPR)
$841,462Terry Van Dyke · Division Of Basic Sciences - Nci · ZIC · FY2012 · CA
Administrative Core
$841,293Roy S Herbst · Yale University · P50 · FY2016 · CA
Role of the Perivascular Microenvironment in Primary and Metastatic Brain Tumors
$841,065Eric C Holland · Fred Hutchinson Cancer Research Center · U54 · FY2015 · CA
Translational Pathology Core Facility
$840,907Sue Ellen Martin · University Of Southern California · P30 · FY2009 · CA
Genetic Features of Gender Differences in COPD
$840,766Dawn L Demeo · Brigham And Women'S Hospital · R01 · FY2008 · HL
Deciphering the Role of Bruton's Tyrosine Kinase in the Host Defense Against Aspergillus fumigatus
$840,687Jatin M Vyas · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Development of a low dose clinical lung screening prototype for early detection of COPD and lung cancer using a novel x-ray source to enable Talbot-Lau interferometry
$840,685David Vine · Sigray, Inc. · R44 · FY2021 · HL
PLCO EEMS and Extended Follow Up
$840,647Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
CHEMOPREVENTION OF LUNG AND ESOPHAGEAL CANCER
$839,784University Of Minnesota Twin Cities · P01 · FY2000 · CA
Modulation of Therapeutic Response
$839,713James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2016 · CA
A cost-effective radiation treatment delivery system for the low- and middle-income countries
$839,655Eric C Ford · University Of Washington · UH3 · FY2021 · CA
Immunobiology of Lung Injury and Fibrosis
$839,331Bethany B. Moore · University Of Michigan At Ann Arbor · R35 · FY2024 · HL
Project 1 - Ethnic Differences in Smoking-Related Biomarkers and Risk of Lung Cancer
$839,292Sungshim Lani Park · University Of Minnesota · P01 · FY2020 · CA
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$838,914William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral Neuropathy
$838,708Cohava Gelber · Serpin Pharma, Llc · R44 · FY2024 · CA
Genetic Features of Gender Differences in COPD
$838,635Dawn L Demeo · Brigham And Women'S Hospital · R01 · FY2010 · HL
Role of IKK alpha in lung cancer development
$838,395Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
DISSECTING THE ROLE OF FOLATE DEFICIENCY IN LUNG CANCER DEVELOPMENT AND GENOMIC INSTABILITY
$838,341Weill Medical College Of Cornell University · · FY2025 · Defense Health Agency
Multidisciplinary Training Program in Lung Disease
$838,264Dean Sheppard · University Of California, San Francisco · T32 · FY2021 · HL
Identification of viral exposure signatures for early detection of liver cancer
$838,170Limin Wang · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA